CPT code 92286 denotes a diagnostic examination focused on the anterior segment of the eye with identification of vascular abnormalities and a formal interpretation and report. This procedure is used when clinicians evaluate front‑segment ocular vasculature for conditions that may include neoplastic changes or other vascular lesions. Nationally, the code matters because it captures a specialized ophthalmic diagnostic service that supports clinical decision‑making and guides subsequent management, imaging, or referral.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical nature of the service, typical sites of service, and the role the code plays in documenting diagnostic interpretation and reporting. The publication outlines benchmarks and billing considerations relevant to outpatient ophthalmology practices, summarizes common modifiers used with diagnostic ophthalmic procedures, and places the code in clinical context for providers, coding staff, and payers.

The content provides a national perspective on the code’s use, highlighting where it fits within ophthalmic diagnostic workflows and what documentation elements underpin appropriate coding. Data not available in the input are noted where applicable.